The two most common prostate diseases are prostatitis and benign hyperplasia (BPH). Prostatitis can be complicated by BPH or be accompanied by periodic exacerbations. Medication is an important component in the overall treatment of the prostate. In addition, treatment often leads to defeat due to improper treatment, missed medications and, when the condition is alleviated, ignoring the disease.
Thus, 20-30% of patients are dissatisfied with the treatment, do not feel a reduction in the symptoms of urological disorders and an improvement in quality of life. Most likely, this is due to a misjudgment of lower urinary tract function in men with BPH and, consequently, to the choice of inadequate treatment.
As you know, prostatitis is acute and chronic (CP), bacterial and bacterial.
Prostatitis in%
- acute bacterial prostatitis - 5-10%.
- chronic bacterial prostatitis - 6-10%
- chronic bacterial prostatitis - 80-90%, including prostatodynia - 20-30%.
The most common is chronic bacterial prostatitis, which must be controlled and exacerbated in time with and without BPH.
The main drugs for the treatment of BPH and chronic prostatitis:
- 5α-reductase inhibitors (finasteride, dutasteride).
- α-blockers (doxazosin, tamsulosin)
- phytotherapy (sabal palm extract);
- antibiotics
- amino acid complexes?
- animal organ extracts (prostate extract);
- insect repellents (products derived from insects).
At the same time, in 13-30% of the effect of the use of α-blockers does not appear within 3 months of treatment - no further treatment with drugs of this group is recommended.
When prescribing finasteride, the doctor should be prepared for the fact that the most important side effects of the drug: impotence, decreased libido, decreased ejaculation volume may lead to self-withdrawal of the drug by the patient.
Treatment of BPH and prostatitis is an important, not completely resolved urological problem.
Frequent exacerbations of CP when there is no evidence of prostate surgery force the physician to use additional methods in drug therapy. Often, the presence of concomitant CP worsens the course of BPH, because inflammation in 80% of cases is in the prostate gland with benign hyperplasia.
Modern medicine gives us new opportunities to treat CP and BPH and prevent exacerbations.